- Home/
- Article /
- Effect of low dose pioglitazone on glycemic control and insulin resistance in Type 2 diabetes: A randomized, double blind, clinical trial.
Full Author : ['Rajagopalan, Sujit', 'Dutta, Pinaki', 'Hota, Debasish', 'Bhansali, Anil', 'Srinivasan, Anand', 'Chakrabarti, Amitava']
Journal Title : Diabetes research and clinical practice
Chapter : Section3
Journal Year : 2015
Cited by : Not Available
This study shows that pioglitazone 7.5 mg/day as an add-on therapy in Southeast Asian patients with Type 2 diabetes is safer and equally efficacious as the 15- and 30-mg doses of pioglitazone. Hence it is prudent to start pioglitazone therapy at a lower d.....
Keywords : ["randomized double blind clinical trial", "low dose pioglitazone", "type diabetes", "insulin resistance", "glycemic control", "effect"]